L. Clarke

发表

Effect of screening and adjuvant therapy on mortality from breast cancer.

D. Berry, A. Yakovlev, J. Habbema, 2006, The New England journal of medicine.

Effect of screening and adjuvant therapy on mortality from breast cancer

D. Berry, A. Yakovlev, J. Habbema, 2005 .

Online tool to guide decisions for BRCA1/2 mutation carriers.

Sylvia K Plevritis, Peter Rust, Lauren Clarke, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Will Knowledge of Gene-Based Colorectal Cancer Disease Risk Influence Quality of Life and Screening Behavior?

P. Newcomb, S. Ramsey, W. Burke, 2009, Public Health Genomics.

The cost-effectiveness of combined androgen blockade with bicalutamide and luteinizing hormone releasing hormone agonist in men with metastatic prostate cancer.

S. Ramsey, D. Penson, L. Clarke, 2005, The Journal of urology.

Is combined androgen blockade with bicalutamide cost-effective compared with combined androgen blockade with flutamide?

S. Ramsey, D. Penson, L. Clarke, 2005, Urology.

Patterns of birth cohort-specific smoking histories, 1965-2009.

E. Feuer, T. Holford, D. Levy, 2014, American journal of preventive medicine.

Impact of Reduced Tobacco Smoking on Lung Cancer Mortality in the United States During 1975–2000

E. Feuer, H. D. de Koning, T. Holford, 2012, Journal of the National Cancer Institute.

Chapter 5: Actual and Counterfactual Smoking Prevalence Rates in the U.S. Population via Microsimulation

Jihyoun Jeon, Rafael Meza, David T Levy, 2012, Risk analysis : an official publication of the Society for Risk Analysis.

Cost Effectiveness of Entecavir versus Lamivudine with Adefovir Salvage in HBeAg-Positive Chronic Hepatitis B

A. Bisceglie, U. Iloeje, R. Gish, 2012, PharmacoEconomics.

Health care use and primary prophylaxis with colony-stimulating factors.

S. Ramsey, L. Clarke, S. Sullivan, 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Family History Assessment to Detect Increased Risk for Colorectal Cancer: Conceptual Considerations and a Preliminary Economic Analysis

M. Khoury, P. Newcomb, S. Ramsey, 2005, Cancer Epidemiology Biomarkers & Prevention.

PCN14 IS COMBINED ANDROGEN BLOCKADE WITH BICALUTAMIDE COST-EFFECTIVE COMPARED WITH COMBINED ANDROGEN BLOCKADE WITH FLUTAMIDE?

S. Ramsey, D. Penson, L. Clarke, 2005 .

Colony‐Stimulating Factor Use and Impact on Febrile Neutropenia Among Patients with Newly Diagnosed Breast, Colorectal, or Non–Small Cell Lung Cancer Who Were Receiving Chemotherapy

S. Ramsey, L. Clarke, D. Blough, 2012, Pharmacotherapy.

Colony-stimulating factor prescribing patterns in patients receiving chemotherapy for cancer.

S. Ramsey, L. Clarke, S. Sullivan, 2010, The American journal of managed care.

Smoking and Lung Cancer Mortality in the United States From 2015 to 2065

E. Feuer, T. Holford, D. Levy, 2018, Annals of Internal Medicine.

Chapter 13: CISNET Lung Models: Comparison of Model Assumptions and Model Structures

William D Hazelton, Pamela M McMahon, Marek Kimmel, 2012, Risk analysis : an official publication of the Society for Risk Analysis.

An Economic Evaluation of Atorvastatin for Primary Prevention of Cardiovascular Events in Type 2 Diabetes

S. Ramsey, L. Clarke, S. Sullivan, 2012, PharmacoEconomics.

Comparing Benefits from Many Possible Computed Tomography Lung Cancer Screening Programs: Extrapolating from the National Lung Screening Trial Using Comparative Modeling

Summer S. Han, E. Feuer, S. Plevritis, 2014, PloS one.

Modeling cancer natural history, epidemiology, and control: reflections on the CISNET breast group experience.

Eric J Feuer, Kathleen A Cronin, Clyde B Schechter, 2006, Journal of the National Cancer Institute. Monographs.

An economic viewpoint on alternative strategies for identifying persons with hereditary nonpolyposis colorectal cancer

S. Ramsey, W. Burke, L. Clarke, 2003, Genetics in Medicine.

28: The Cost-Effectiveness of Combined Androgen Blockade with Bicalutamide and LHRH Agonist in Men with Stage D2 Prostate Cancer

S. Ramsey, D. Penson, L. Clarke, 2005 .

Genetic Simulation Resources: a website for the registration and discovery of genetic data simulators

Bo Peng, John Clarke, Huann-Sheng Chen, 2013, Bioinform..

A comparative review of CISNET breast models used to analyze U.S. breast cancer incidence and mortality trends.

Eric J Feuer, Kathleen A Cronin, Sylvia K Plevritis, 2006, Journal of the National Cancer Institute. Monographs.

Impact of adjuvant therapy and mammography on U.S. mortality from 1975 to 2000: comparison of mortality results from the cisnet breast cancer base case analysis.

E. Feuer, S. Plevritis, K. Cronin, 2006, Journal of the National Cancer Institute. Monographs.

Diversity of model approaches for breast cancer screening: a review of model assumptions by The Cancer Intervention and Surveillance Network (CISNET) Breast Cancer Groups

Sylvia Plevritis, Lauren Clarke, S. Plevritis, 2004, Statistical methods in medical research.

Additional common inputs for analyzing impact of adjuvant therapy and mammography on U.S. mortality.

E. Feuer, A. Mariotto, K. Cronin, 2006, Journal of the National Cancer Institute. Monographs.

Evaluation of erlotinib in advanced non-small cell lung cancer: impact on the budget of a U.S. health insurance plan.

D. Lubeck, S. Ramsey, L. Clarke, 2006, Journal of managed care pharmacy : JMCP.